Ruping Zhao
Overview
Explore the profile of Ruping Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhao Y, Gu S, Li L, Zhao R, Xie S, Zhang J, et al.
Neuro Oncol
. 2023 Jun;
25(12):2207-2220.
PMID: 37379245
Background: Brain metastasis (BM) are a devastating consequence of lung cancer. This study was aimed to screen risk factors for predicting BM. Methods: Using an in vivo BM preclinical model,...
12.
Zhao Z, Fan Y, Cui Y, Yang L, Wu Y, Yuan Y, et al.
Toxicol Res (Camb)
. 2023 May;
12(2):201-215.
PMID: 37125330
Introduction: Qishenbuqi capsule (QSBQC), a listed Chinese patent prescription, comprises of 4 herbs. Clinically, it has been shown to improve immune functions. Methods: Subjects with deficiency and non- deficiency were...
13.
Zhang K, Ying H, Zhao R, Chen Y, Deng Q
Chin Herb Med
. 2022 Sep;
14(1):111-116.
PMID: 36120123
Objective: To investigate the potential effect of capilliposide (LCC) on the chemo sensitivity and the stemness of human ovarian cancer cells. Methods: Cell Counting Kit-8 (CCK8) was used to measure...
14.
Yin W, Zhang K, Deng Q, Yu Q, Mao Y, Zhao R, et al.
Bioengineered
. 2021 Oct;
12(1):8679-8689.
PMID: 34635007
Glioma is an intracranial malignant tumor with high morbidity in China. Limited efficacy has been achieved in the treatment of glioma through the application of epidermal growth factor receptor (EGFR)...
15.
Ying H, Zhao R, Yu Q, Zhang K, Deng Q
Drug Dev Res
. 2021 Sep;
83(2):512-524.
PMID: 34541682
Circular RNAs (circRNAs) play vital regulatory roles in the development of ovarian cancer (OC). However, the functions of circRNA Atlastin GTPase 2 (circATL2) in paclitaxel (PTX) resistance of OC are...
16.
Yue J, Wu Y, Qiu L, Zhao R, Jiang M, Zhang H
Am J Cancer Res
. 2021 May;
11(4):1051-1068.
PMID: 33948345
Cancer stem cells (CSCs) are a cellular subpopulation accelerating cancer cell growth, invasion and metastasis and survival. After chemoradiotherapy, CSCs are enriched because of their survival advantages and lead to...
17.
Zhao R, Yu X, Feng Y, Wang J, Chen Y, Mao Y, et al.
Asia Pac J Clin Oncol
. 2020 Apr;
16(4):266-272.
PMID: 32285607
Aim: To evaluate the role of radiotherapy (RT) in the treatment of localized primary adult rhabdomyosarcoma (RMS). Methods: This retrospective study identified 62 consecutive adult patients with localized primary RMS...
18.
Zhao R, Yu X, Feng Y, Wang J, Mao Y, Yin W, et al.
Jpn J Clin Oncol
. 2018 Jul;
48(9):799-805.
PMID: 30060202
Background: We hypothesized that survival varied significantly between retroperitoneal soft tissue sarcoma (STS) and extremity/trunk STS. This study explored the reasons for the different outcomes and identified patient characteristics for...
19.
Zhao R, Yu X, Feng Y, Yang Z, Chen X, Wand J, et al.
Asia Pac J Clin Oncol
. 2017 Oct;
14(2):e109-e115.
PMID: 29071781
Aim: The aim of this study was to determine the effect of local recurrence on overall survival in patients with intermediate high-grade localized primary soft tissue sarcoma (STS) of extremity...
20.
Song T, Zhang X, Fang M, Zhao R, Wu S
Cancer Med
. 2016 Dec;
5(12):3371-3377.
PMID: 27925455
This prospective study aimed at assessing the efficiency and safety of concurrent chemoradiotherapy (CCRT) using paclitaxel (PTX) plus oxaliplatin (OHP) in unresectable locally advanced esophageal cancer patients. Between January 2006...